Back to Search Start Over

Salmonella Typhimurium exhibits fluoroquinolone resistance mediated by the accumulation of the antioxidant molecule H2S in a CysK-dependent manner.

Authors :
Frávega J
Álvarez R
Díaz F
Inostroza O
Tejías C
Rodas PI
Paredes-Sabja D
Fuentes JA
Calderón IL
Gil F
Source :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2016 Dec; Vol. 71 (12), pp. 3409-3415. Date of Electronic Publication: 2016 Aug 15.
Publication Year :
2016

Abstract

Objectives: To evaluate the contribution of cysK and cysM to the fluoroquinolone (ofloxacin) antibiotic resistance in Salmonella Typhimurium, and their impact on H <subscript>2</subscript> S and cysteine production through targeted mutagenesis.<br />Methods: Salmonella Typhimurium 14028s and its cysK and cysM mutants were tested for their susceptibility to ofloxacin, as determined by a broth microdilution test (to determine the MIC) and survival curves. H <subscript>2</subscript> S levels were measured by the Pb(AC) <subscript>2</subscript> method and cysteine levels were determined using 5,5-dithio-bis-2-nitrobenzoic acid. DNA damage induced by antibiotic treatment was determined by PFGE. Finally, expression of cysK and cysM genes under antibiotic treatment was determined by real-time reverse transcription PCR.<br />Results: As determined by MIC, the ΔcysK strain was more resistant to ofloxacin, a reactive oxygen species (ROS)-producing fluoroquinolone, than the WT and ΔcysM strains, which correlates with survival curves. Moreover, the ΔcysK strain exhibited higher H <subscript>2</subscript> S levels and lower cysteine levels than the WT strain. Finally, the ΔcysK strain exhibited lower DNA damage upon challenge with ofloxacin than the WT and ΔcysM strains. These results are in accordance with lower expression of cysK under ofloxacin treatment in the WT strain.<br />Conclusions: This work demonstrated that cysteine metabolism in Salmonella Typhimurium modulated H <subscript>2</subscript> S levels, conferring resistance to second-generation fluoroquinolones.<br /> (© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.)

Details

Language :
English
ISSN :
1460-2091
Volume :
71
Issue :
12
Database :
MEDLINE
Journal :
The Journal of antimicrobial chemotherapy
Publication Type :
Academic Journal
Accession number :
27530757
Full Text :
https://doi.org/10.1093/jac/dkw311